NCT03303976View on ClinicalTrials.gov

Phase I to Test a New Pneumococcal Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 7, 2017

Primary Completion Date

September 12, 2018

Study Completion Date

September 12, 2018

Conditions
Pneumococcal PneumoniaPneumonia, Bacterial
Interventions
BIOLOGICAL

Bioconjugate pneumococcal vaccine

Bioconjuagte vaccine against bacterial pneumococcal infection

BIOLOGICAL

Multivalent plain polysaccharide vaccine

Multivalent plain polysaccharide vaccine against bacterial pneumococcal infection

Trial Locations (1)

Unknown

CRS, Mönchengladbach

Sponsors
All Listed Sponsors
lead

LimmaTech Biologics AG

INDUSTRY

NCT03303976 - Phase I to Test a New Pneumococcal Vaccine | Biotech Hunter | Biotech Hunter